Market Overview:
The global pentazocine market is expected to grow at a CAGR of 3.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of pain, rising geriatric population, and growing demand for pentazocine injections and tablets. However, the high cost of treatment and side effects associated with pentazocine are expected to restrain the growth of this market during the forecast period. On the basis of type, the global pentazocine market is segmented into injections and tablets. The injection segment is expected to account for a larger share than that of tablets in 2018 owing to its higher usage in hospitals and clinics across regions. On the basis of application, adults are estimated to account for a larger share than children or elderly in 2018 due to their higher vulnerability towards pain conditions such as cancer or post-operative pain.
Product Definition:
Pentazocine is a Schedule IV narcotic analgesic drug used to treat moderate to severe pain. It can be administered orally, intravenously, or intramuscularly. Pentazocine is often prescribed for postoperative pain and for relief of cancer pain.
Injections:
Injections is a method of delivering drugs that are larger than molecules and smaller than cells. They can be administered by two methods, either by direct injection into the vein or by oral administration. Injections have certain advantages over other drug delivery systems such as high bioavailability, immediate effect on the target organ (in case of injectable), easy self-administration (in case of oral tablets) and minimal adverse effects.
Tablets:
Tablets are small solid dosage forms that contain the active ingredient(s) and are usually taken by mouth. Tablets can be easily disintegrated and they have a uniform coating of the drug. They also offer convenience in terms of storage as they do not need to be stored in a refrigerator like liquid drugs do, which is another reason why tablets are preferred over liquids or capsules.
Application Insights:
The pain management segment dominated the global pentazocine market in terms of revenue share in 2017. The high prevalence of chronic pain disorders, such as arthritis and headache is anticipated to drive the segment growth during the forecast period. Moreover, increasing awareness about non-opioid alternatives for pain management is expected to result in a reduced demand for pentazocine injections over the next few years.
However, growing awareness regarding drug abuse and rising number of opioid prescriptions are expected to pose a threat to this application segment by 2030 due to which this drug will lose its dominance position. In addition, stringent government regulations relatedto safety concerns regarding opioids are projectededto restrictpentazocine market growth duringthe forecast period thereby hampering overall industry expansion over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The U.S., in particular, is a major contributor to the regional market growth owing to high demand for pain management therapies and opioid-containing products. Furthermore, increasing cases of chronic pain are expected to drive the regional product demand over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period due to factors such as growing geriatric population and rising healthcare expenditure levels in emerging economies such as China and India.
Growth Factors:
- Increasing prevalence of pain: The global prevalence of pain is increasing due to the aging population, rising obesity rates, and increasing number of people with chronic diseases. This is expected to drive the demand for pentazocine in the coming years.
- Growing use of pentazocine in palliative care: Pentazocine is increasingly being used as a part of palliative care for patients with terminal illnesses such as cancer. This is expected to boost the growth of the market in the coming years.
- Rising awareness about pentazocine: There has been an increase in awareness about pentazocine among healthcare professionals and consumers over recent years owing to its benefits over other analgesics drugs available in the market. This is likely to propel demand for this drug in future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pentazocine Market Research Report
By Type
Injections, Tablets
By Application
Adults, Children, Elderly
By Companies
Teva, pfizer, Merck KGaA, LUPIN PHARMACEUTICALS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Pentazocine Market Report Segments:
The global Pentazocine market is segmented on the basis of:
Types
Injections, Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children, Elderly
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- pfizer
- Merck KGaA
- LUPIN PHARMACEUTICALS
Highlights of The Pentazocine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injections
- Tablets
- By Application:
- Adults
- Children
- Elderly
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pentazocine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pentazocine is a medication used to relieve pain. It is an opioid drug, meaning it works by binding to receptors in the brain and spine that control pain. Pentazocine may also be used for other purposes, such as sedation (to make you feel sleepy) or as part of anesthesia.
Some of the major players in the pentazocine market are Teva, pfizer, Merck KGaA, LUPIN PHARMACEUTICALS.
The pentazocine market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pentazocine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pentazocine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pentazocine Market - Supply Chain
4.5. Global Pentazocine Market Forecast
4.5.1. Pentazocine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pentazocine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pentazocine Market Absolute $ Opportunity
5. Global Pentazocine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pentazocine Market Size and Volume Forecast by Type
5.3.1. Injections
5.3.2. Tablets
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pentazocine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pentazocine Market Size and Volume Forecast by Application
6.3.1. Adults
6.3.2. Children
6.3.3. Elderly
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pentazocine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pentazocine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pentazocine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pentazocine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pentazocine Demand Share Forecast, 2019-2026
9. North America Pentazocine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pentazocine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pentazocine Market Size and Volume Forecast by Application
9.4.1. Adults
9.4.2. Children
9.4.3. Elderly
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pentazocine Market Size and Volume Forecast by Type
9.7.1. Injections
9.7.2. Tablets
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pentazocine Demand Share Forecast, 2019-2026
10. Latin America Pentazocine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pentazocine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pentazocine Market Size and Volume Forecast by Application
10.4.1. Adults
10.4.2. Children
10.4.3. Elderly
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pentazocine Market Size and Volume Forecast by Type
10.7.1. Injections
10.7.2. Tablets
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pentazocine Demand Share Forecast, 2019-2026
11. Europe Pentazocine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pentazocine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pentazocine Market Size and Volume Forecast by Application
11.4.1. Adults
11.4.2. Children
11.4.3. Elderly
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pentazocine Market Size and Volume Forecast by Type
11.7.1. Injections
11.7.2. Tablets
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.0.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pentazocine Demand Share, 2019-2026
12. Asia Pacific Pentazocine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pentazocine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pentazocine Market Size and Volume Forecast by Application
12.4.1. Adults
12.4.2. Children
12.4.3. Elderly
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pentazocine Market Size and Volume Forecast by Type
12.7.1. Injections
12.7.2. Tablets
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pentazocine Demand Share, 2019-2026
13. Middle East & Africa Pentazocine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pentazocine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pentazocine Market Size and Volume Forecast by Application
13.4.1. Adults
13.4.2. Children
13.4.3. Elderly
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pentazocine Market Size and Volume Forecast by Type
13.7.1. Injections
13.7.2. Tablets
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pentazocine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pentazocine Market: Market Share Analysis
14.2. Pentazocine Distributors and Customers
14.3. Pentazocine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck KGaA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LUPIN PHARMACEUTICALS
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
